Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Palmitic acid
Price: Check
Purity: 98.0%
Stocking Period: 10 Day
Contact: Yang
Email: sales@echemcloud.com

Dayang Chem (Hangzhou) Co., Ltd.
China
Product Name: disodium 4-hydroxy-3-[[2-(hydroxy-oxido-phosphoryl)acetyl]amino]-4-oxo-butanoate
Price: $Inquiry/100g $Inquiry/1kg $Inquiry/100kg $Inquiry/1000kg
Purity: 98.0%
Stocking Period: Inquiry
Contact: Ms Wang
Email: enquiry@dycnchem.com

60342-56-5

60342-56-5 structure

60342-56-5 structure

Name: disodium 4-hydroxy-3-[[2-(hydroxy-oxido-phosphoryl)acetyl]amino]-4-oxo-butanoate
Chemical Name: pala
CAS Number: 60342-56-5
Molecular Formula: C₆H₁₀NNaO₈P+
Molecular Weight: 278.10900
Create Date: 2017-05-31 08:22:33
Modify Date: 2025-10-04 20:13:43

Name	pala
Synonyms	L-2-ammonio-4-oxobutanoate (2S)-2-ammonio-4-oxobutanoate N-phosphonoacetyl-L-aspartate de sodium L-aspartate-4-semialdehyde L-aspartate semialdehyde N-(phosphonoacetyl)-,tetrasodium salt aspartate semi-aldehyde

Molecular Formula	C₆H₁₀NNaO₈P+
Molecular Weight	278.10900
Exact Mass	278.00400
PSA	171.04000

CHEMICAL IDENTIFICATION

RTECS NUMBER :: CI9470000

CHEMICAL NAME :: L-Aspartic acid, N-(phosphonoacetyl)-, tetrasodium salt

CAS REGISTRY NUMBER :: 60342-56-5

LAST UPDATED :: 198803

DATA ITEMS CITED :: 2

MOLECULAR FORMULA :: C6-H10-N-O8-P.4Na

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 1763 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) Volume(issue)/page/year: JAN1986

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 530 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) Volume(issue)/page/year: JAN1986

Precursor 0
DownStream 1
56-84-8

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.